All of the witnesses testified that Beckman Coulter had a fixed price for the circuit boards and there was no contractual justification for this additional charge. On AugDovatron insisted that Beckman Coulter pay an additional $300,000 that was not otherwise required to be paid by Beckman under the terms of their contract. This occurred approximately on August 24, 1998. After a ten month FDA validation process Dovatron received an FDA certification so that the boards manufactured by Dovatron could be used in the medical instruments sold by Beckman Coulter. After a one-year selection process, Beckman Coulter chose Dovatron Manufacturing, Inc., the tenth largest electrical component manufacturing company in the world.īeckman Coulter and Dovatron entered a partially written, partially oral contract in 1998 for Dovatron to manufacture its circuit boards. Since Beckman Coulter's core competency is not in the manufacture of circuit boards it sought to outsource the manufacture of the circuit boards to an electrical component manufacturer. An integral part of the LX20 are 37 separate circuit boards. One of these instruments is the LX20 Blood Analyzer. Callahan & Blaine Wins $934 Million for Beckman Coulterīeckman Coulter manufactures medical instruments used by hospitals, clinics and research centers throughout the world.
0 kommentar(er)
